‹ All Posts
Lovelesh Sharma

3 mins ago · SEBI Registration INH000027937

Will Aurobindo’s ₹1,800 Pause Resolve Higher?

THE CONSOLIDATION AUROPHARMA Aurobindo Pharma’s chart dated 20 November shows price at ₹1,799 after a sharp advance from the October low. The broader sequence remains upward, while the latest candles are consolidating beneath the November peak around ₹1,850–1,860. THE SUPPORT TEST The 20-day average at ₹1,797.82 and the 50-day average at ₹1,799.72 are almost aligned with price. This makes the current area a decision point rather than a confirmed support base. The latest session low at ₹1,788.1 provides the first downside reference. The Z-score has eased to 0.65 from above +2 during the rally. The earlier positive stretch has unwound while price remains near its highs, consistent with a pause in momentum. It does not yet confirm that another advance has started. WHAT WOULD SIGNAL STRENGTH? A sustained close above the latest session high of ₹1,817.50 would be an initial improvement. Follow-through above the nearby ₹1,830 area would strengthen the case for a retest of the November peak. Holding the ₹1,790–1,800 region on a subsequent pullback would add confidence. WHEN TO REASSESS A close below ₹1,788 would weaken the immediate consolidation and shift attention toward ₹1,770–1,780. A deeper break could expose ₹1,750. Watch whether buyers establish a higher low before expecting the broader uptrend to resume.

#Today’sTradingSetup#WatchOutFor#TechnicalViews#HiddenGems
AUROPHARMA_2026-11-20.png.png